Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase 2b, randomised double blind placebo controlled multicentre study to evaluate the effects of pentosan polysulfate sodium on treating pain in subjects with osteoarthritis of the knee and subchondral bone marrow lesions

Trial Profile

A phase 2b, randomised double blind placebo controlled multicentre study to evaluate the effects of pentosan polysulfate sodium on treating pain in subjects with osteoarthritis of the knee and subchondral bone marrow lesions

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 05 Oct 2018

At a glance

  • Drugs Pentosan polysulfate (Primary)
  • Indications Pain
  • Focus Therapeutic Use
  • Acronyms PARA005
  • Sponsors Paradigm Biopharma
  • Most Recent Events

    • 06 Aug 2018 Actual date last participant enrolled was 8/2/2018
    • 06 Aug 2018 Planned End Date changed from 18 Dec 2018 to 2 Feb 2019.
    • 06 Aug 2018 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top